Abstract submission
RSNA's Cutting-Edge Research call for abstracts is open!
Your discoveries have the power to impact the future of individuals worldwide. Don't miss the final opportunity to showcase your groundbreaking research at RSNA 2025.
We're accepting research on the following topics:
Opportunistic Screening: Enhancing Diagnostic Impact from Routine Imaging
This topic explores how radiologists can extract additional, clinically-relevant information from routine imaging studies performed for other indications, such as:
- Body composition
- Assessing bone mineral density
- Identifying coronary artery calcifications on CT
Translating Innovation: Radiologist–Industry Collaboration in Clinical Integration of New Technologies
Focusing on the dynamic interface between scientific discovery and clinical application, this topic highlights research that results from collaboration between radiologists and industry.
Submissions may include:
- Co-development and real-world deployment of AI applications, including:
- Diagnostic support tools
- Workflow optimization platforms
- Imaging triage systems
- Advances in imaging hardware and software
Next-Generation Imaging: Advances in Low- and Non-Contrast Techniques
This topic addresses innovative imaging methods that minimize or eliminate the need for exogenous contrast, including:
- Development of novel sequences
- Clinical implementation
- Comparative effectiveness
- Cost analysis
- Environmental benefits
- Safety
- Diagnostic efficacy
Imaging-Guided Oncologic Therapies: From Histotripsy to Theranostics and Beyond
Emphasis is placed on how radiologists are central to both the diagnostic and therapeutic continuum in precision oncology through image-guided delivery and response assessment.
High-Impact Clinical Trials in Radiology
Abstracts must meet the following criteria:
- Prospective study design
- Conducted across multiple centers
- Centered on radiology or medical imaging
- Demonstrate clear potential to impact clinical practice
- Include data/outcomes collected after May 7, 2025
- Not submitted during the spring RSNA 2025 call for abstracts
Submission deadline
Submit your work to the Cutting-Edge Research call for abstracts by Aug. 6, noon CT. Authors can expect to receive submission status notifications by email.
Please note: Accepted presenters of a scientific paper, scientific poster, education exhibit and/or quality improvement reports for the RSNA annual meeting will receive a 50% discount off their in-person registration rate.
Contact us
If you have questions, please contact us at programs@rsna.org or call 1-877-776-2227 (within U.S.) or 1-630-590-7774 (outside U.S.).
For technical support, please contact us at rsna@support.ctimeetingtech.com or call 1-217-398-1792.
Types of abstracts
Scientific presentation
Hypothesis-driven research that may be submitted as a paper to be presented orally or as a digital presentation.
Education exhibit
Education exhibits should be designed to teach or review topics related to medical imaging. They may be presented as digital presentations or standalone exhibits.
Quality improvement report
A presentation of quality assessment and improvement initiatives aimed at improving patient care in radiology. Reports will be presented as digital presentations and all require an oral presentation.
Abstract submission overview
Submit abstracts for consideration using an online submission program, which allows you to save and edit your work during the submission period. All abstracts must be submitted online by the posted deadlines in order to be considered for acceptance.
You retain the copyright of your content and agree to give RSNA a limited, nonexclusive, royalty-free license to present and archive the content.
Abstract review process
Recognizing excellence
Kuo York Chynn neuroradiology research award
Trainee research prizes
Education exhibit awards
Quality improvement report awards
Scientific poster awards
RSNA CME Activity Disclosure
Disclosure Refusal Statement
*Financial Disclosure
As an ACCME-accredited provider, the RSNA must ensure that education is fair and balanced and that any clinical content presented supports safe, effective patient care. The ACCME defines ineligible companies as "those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients."
Further, the provider must be able to show that individuals in a position to control the content of an education activity, including committee members, reviewers, planners, authors, and presenters, has disclosed all financial relationships with ineligible companies to the provider. Individuals in a position to control the content must disclose regardless of their view of the relevance of the relationship to the education. The provider must identify, mitigate, and disclose all identified financial relationships to an education activity being delivered to the learners.
If you have or have had within the previous 24 months such a relationship or affiliation, you must disclose this information. Likewise, disclosure that no relationship(s) exists is also required. The intent of this policy is not to prevent an individual with a financial relationship from participating; however, in accordance with ACCME standards, the RSNA has developed policies and procedures to manage identified financial relationships.